CIK 0002091349 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
First Tracks Biotherapeutics, Inc.
Sign in to watch- Ticker
- TRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 395003207
- Phone
- 212-373-3000
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- Biopharma Company, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,145
- in 1 filing
Net −$1,758,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | FENTON DENNIS M Director | Grant or award · Stock Option (right to buy) | +42,000 | 42,000 | ||
| 2026-04-23 | Tamboli Ajim Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +41,234 | 41,234 | ||
| 2026-04-22 | Tamboli Ajim Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +41,233 | 41,233 | ||
| 2026-04-21 | Tamboli Ajim Chief Financial Officer | Grant or award · Restricted Stock Unit | +45,700 | 45,700 | ||
| 2026-04-21 | Tamboli Ajim Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +41,233 | 41,233 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +28,571 | 28,571 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +10,694 | 10,694 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +9,200 | 9,200 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +10,600 | 10,600 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Restricted Stock Unit | +6,030 | 6,030 | ||
| 2026-04-20 | Ware J. Anthony Director | Grant or award · Restricted Stock Unit | +4,000 | 4,000 | ||
| 2026-04-20 | Lizzul Paul F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +83,500 | 83,500 | ||
| 2026-04-20 | Lizzul Paul F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 |
Page 4 of 8 · 151 trades